VRNO

Verano Holdings Corp.

Healthcare · Drug Manufacturers - Specialty & Generic

$305.95 sample

+2.46 (+0.81%) 1D

Market cap

$1.43T

Price as of

2026-10-15

Latest filing

8-K · 2026-09-21

Alerts

8

Price$305.95 +2.00% 3M daily closessample

318.41283.72

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 08INSInsider sell: 10% owner
Oct 02INSInsider sell: 10% owner
Sep 28INSInsider buy: EVP, Operations
Sep 21SECForm 144 filed
Sep 14INSInsider buy: EVP, Operations
Sep 03INSInsider buy: General Counsel
Aug 28INSInsider buy: Chief Executive Officer
Aug 24INSInsider sell: 10% owner

Sign up to see the real VRNO record →

Company facts

SEC EDGAR registration

Name: Verano Holdings Corp.
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: +27sample, -100 to +100
Reporting currency: USD

Who is positioning in VRNO

sample

Insiders: 17 insider transactions over 90 days, net selling, $542.4M
Congress: 5 members traded over 90 days
Institutions · 13F: 41 funds hold $13.7B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$33.2B +23.6% y/y

Q4 2024Q3 2026

Inventory$19.4B +10.9% y/y

Q4 2024Q3 2026

Accounts receivable$14.6B +19.8% y/y

Q4 2024Q3 2026

Total debt$39.0B +17.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $279.6B +9.4% 3M
Sample peer B: $622.8B -2.6% 3M
Sample peer C: $919.3B -9.3% 3M
Sample peer D: $1.19T +10.2% 3M
Sample peer E: $585.7B +7.5% 3M